What does BioStem Technologies, Inc. do?
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a human connective tissue matrix compromised of amniotic tissue intended for wound covering; Vendaje…
What is BioStem Technologies, Inc.'s P/E and P/B ratio?
BioStem Technologies, Inc. has a P/E ratio of 1.9 and a P/B ratio of 1.12.
What is BioStem Technologies, Inc.'s debt-to-equity ratio?
BioStem Technologies, Inc. has a debt-to-equity ratio of 0.04.
How much does BioStem Technologies, Inc. owe compared with what it owns?
BioStem Technologies, Inc. owes $0.43 for every $1 it owns (balance sheet Jun 2026), which is low.
What is BioStem Technologies, Inc.'s Positivity rank?
BioStem Technologies, Inc. is ranked #80 of 6,775 companies globally and #20 of 4,000 in United States on PositoAI, with a Positivity Score of 25,659.
Does BioStem Technologies, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for BioStem Technologies, Inc..
Where can I read the latest news about BioStem Technologies, Inc.?
Recent headlines about BioStem Technologies, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does BioStem Technologies, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of BioStem Technologies, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.